Shopping Cart
- Remove All
- Your shopping cart is currently empty
Envafolimab (ASC 22; KN 035), a recombinant humanized single-domain anti-PD-L1 antibody, integrates the anti-PD-L1 domain with the Fc fragment of the human IgG1 antibody. It inhibits the PD-L1 and PD-1 interaction with an IC50 of 5.25 nM, indicating its research potential for solid tumors [1] [2] [3].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $213 | 7-10 days | |
5 mg | $562 | 7-10 days | |
10 mg | $893 | 7-10 days | |
25 mg | $1,320 | 7-10 days | |
50 mg | $1,780 | 7-10 days |
Description | Envafolimab (ASC 22; KN 035), a recombinant humanized single-domain anti-PD-L1 antibody, integrates the anti-PD-L1 domain with the Fc fragment of the human IgG1 antibody. It inhibits the PD-L1 and PD-1 interaction with an IC50 of 5.25 nM, indicating its research potential for solid tumors [1] [2] [3]. |
Cas No. | 2102192-68-5 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.